Frontiers in Anti-Infective Drug Discovery

Author(s): Edda Russo and Amedeo Amedei

DOI: 10.2174/9781681085623118070003

The Role of the Microbiota in the Genesis of Gastrointestinal Cancers

Pp: 1-44 (44)

Buy Chapters
  • * (Excluding Mailing and Handling)

Frontiers in Anti-Infective Drug Discovery

Volume: 7

The Role of the Microbiota in the Genesis of Gastrointestinal Cancers

Author(s): Edda Russo and Amedeo Amedei

Pp: 1-44 (44)

DOI: 10.2174/9781681085623118070003

* (Excluding Mailing and Handling)

Abstract

The term “Gastro-Intestinal (GI) cancer” indicates a group of tumors that affect the digestive system. Despite progress in treatment, these widespread types of malignant condition represent a serious health problem in the world. GI cancer is a multi-factorial and multi-stage involved disorder, its progression is influenced by environmental and genetic elements and the involvement of microbial population has also recently been recognized in many studies. Today, Next Generation Sequencing (NGS) approach has been used to elucidate the involvement of microorganisms in initiating and facilitating the process of GI cancer. In this chapter, we would like to clarify the role played by the gastrointestinal microflora in the genesis of GI cancers. This chapter will draw the state of the art in the study of the GI microbiota and how the dysbiosis could affect oncogenesis, tumor progression and response to cancer.


Keywords: Cytokines, Dysbiosis, Gastro-Intestinal cancer, Gut microbiota, Helicobacter pylori, Immune system, Next Generation Sequencing.

Related Journals

Related Books